Addus HomeCare (NASDAQ:ADUS) EVP Cliff Donald Blessing Sells 3,499 Shares of Stock

Key Points

• Addus HomeCare EVP Cliff Donald Blessing sold 3,499 shares for about $433,561 at an average price of $123.91, reducing his direct holdings by 34.36% to 6,684 shares. He had also sold 2,000 shares earlier in the month.
• The stock traded down 1.4% to $123.72. In its latest quarter, Addus beat EPS estimates ($1.83 versus $1.79), while revenue of $387.74 million came in slightly below expectations and grew 7% year over year.
• Analyst sentiment is broadly positive: MarketBeat reports a “Moderate Buy” consensus and a $134.70 average target price; Truist and TD Cowen recently raised their targets and maintained Buy ratings.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Cliff Donald Blessing sold 3,499 shares of the firm's stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $123.91, for a total transaction of $433,561.09. Following the completion of the transaction, the executive vice president directly owned 6,684 shares in the company, valued at $828,214.44. This trade represents a 34.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Cliff Donald Blessing also recently made the following trade(s):

• On Friday, November 6th, Cliff Donald Blessing sold 2,000 shares of Addus HomeCare stock. The stock was sold at an average price of $124.18, for a total transaction of $248,360.00.

Addus HomeCare Trading Down 1.4%

NASDAQ ADUS traded down $1.77 during trading hours on Thursday, hitting $123.72. The company's stock had a trading volume of 135,729 shares, compared to its average volume of 237,235. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $131.59. The firm has a market capitalization of $2.30 billion, a P/E ratio of 20.62, a PEG ratio of 1.66 and a beta of 0.75. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average of $118.19 and a 200 day moving average of $107.10.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping analysts' consensus estimates of $1.79 by $0.04. The firm had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.56 EPS. Equities research analysts forecast that Addus HomeCare Corporation will post 6.41 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of recent analyst reports. Zacks Research upgraded Addus HomeCare from a "hold" rating to a "strong-buy" rating in a report on Tuesday. Weiss Ratings upgraded Addus HomeCare from a "hold (c)" rating to a "hold (c+)" rating in a report on Thursday, September 24th. Truist Financial raised their target price on Addus HomeCare from $135.00 to $148.00 and gave the stock a "buy" rating in a report on Thursday, November 5th. TD Cowen boosted their target price on Addus HomeCare from $131.00 to $145.00 and gave the stock a "buy" rating in a research report on Thursday, November 5th. Finally, Barclays upped their price target on Addus HomeCare from $96.00 to $101.00 and gave the company an "underweight" rating in a research note on Wednesday, November 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Addus HomeCare currently has a consensus rating of "Moderate Buy" and a consensus target price of $134.70.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors have recently added to or reduced their stakes in ADUS. BlackRock Inc. acquired a new position in Addus HomeCare in the 2nd quarter worth $344,153,000. Dimensional Fund Advisors LP raised its stake in shares of Addus HomeCare by 11.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock valued at $69,689,000 after purchasing an additional 78,415 shares during the period. Bank of America Corp DE acquired a new stake in shares of Addus HomeCare in the 2nd quarter valued at about $35,527,000. TimesSquare Capital Management LLC acquired a new stake in shares of Addus HomeCare in the 2nd quarter valued at about $31,502,000. Finally, Boston Partners lifted its holdings in shares of Addus HomeCare by 18.0% in the third quarter. Boston Partners now owns 290,332 shares of the company's stock valued at $32,222,000 after purchasing an additional 44,279 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.